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Contingency management (CM) programs that arrange reinforcement of biologically-
verified abstinence are among the most powerful treatments for a wide range of substance 
use disorders (Castells et al., 2009; Lussier et al., 2006; Prendergast et al., 2006). 
Nevertheless, these programs are underutilized despite solid scientific support for their 
ability to produce clinically meaningful reductions in substance use (e.g., Benishek et al., 
2010). To better understand this trend, a considerable amount of research (McGovern et al., 
2004; Rash et al., 2012; Willenbring et al., 2004), including our own (Kirby et al., 2006; 
Benishek et al., 2010; Kirby et al., 2012), has focused on evaluating treatment providers’ 
utilization and opinion of CM approaches. Two articles in this issue of American Journal of 
Drug and Alcohol Abuse (AJDAA) further the important discussion regarding the 
implementation of CM in community substance abuse treatment settings: Hartzler and 
Garrett (2016) examine client preferences regarding programmatic aspects of CM, and 
López-Núñez et al. (2016) address its cost-effectiveness, concluding that CM substantially 
increases smoking abstinence and that investing small additional amounts of money can 
result in greater benefits.
The Hartzler and Garrett article encourages us to consider clients’ perceptions about 
incentives and two key variables in reinforcement-based interventions, such as CM: 
reinforcement schedule (fixed vs variable) and reinforcement delay. They found that clients 
prefer a predictable fixed schedule, where a reinforcer is delivered every time substance 
abstinence is biologically verified, as opposed to a variable schedule where abstinence may 
not be rewarded each time. This finding has implications for the fishbowl procedure 
developed by Petry and her colleagues (e.g., Petry et al., 2000; Peirce et al., 2006). The 
fishbowl procedure allows clients to draw slips of paper from a bowl; half which indicate the 
person has won a prize of varying size (“small,” “large,” “jumbo”) and half indicating no 
reward at all (“try again”). This produces a variable schedule of reinforcement that does not 
allow clients to predict how much they will earn. In contrast, the escalating schedule 
developed by Higgins and his colleagues (Higgins et al., 1991) results in payment each time 
abstinence is verified. Like fixed schedules of reinforcement, the escalating schedule 
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delivers a reinforcer (i.e., voucher) every time the desired behavior occurs, but the 
magnitude varies in a predictable way. For example, each time the client demonstrates 
continued abstinence by submitting another consecutive sample that tests negative for a 
substance, the reinforcer increases by a fixed amount (e.g., $1.25). In this way, the longer the 
client maintains abstinence, the greater the value of the voucher. Based on Hartzler and 
Garrett’s findings, we might predict that clients would prefer the escalating schedule, but 
additional studies that actually expose clients to the two schedules and ask them to select 
one (as opposed to asking a hypothetical question) is needed to fully understand their 
preferences for schedules of reinforcement that have been empirically established as 
efficacious.
With respect to reinforcement delay, Hartzler and Garrett report that clients prefer distal 
distribution of earned incentives; that is, they would rather save up points earned during CM 
and exchange them later than be required to accept a cash reward immediately. They 
comment that this is in contrast to the well-established guidelines that indicate that 
immediate delivery of reinforcement is more effective than delayed reinforcement for 
shaping client behavior. Although the immediate impression is that clients’ preferences are 
in conflict with guidelines for using reinforcement effectively, this is not necessarily so. 
Hartzler and Garrett’s survey question asked “If you were able to earn vouchers would you 
rather…earn $5 per week for 10 weeks or save weekly points for 10 weeks to earn $50.” 
This question seems to imply that the point vouchers are given immediately – it is the 
exchange that is delayed. Vouchers constitute a token economy, and it has long been known 
that in token economies, the token (voucher) becomes a conditioned reinforcer that “bridges 
the delay between the target response and backup reinforcement” (Kazdin & Bootzin, 1972). 
For some individuals (e.g., those with limited verbal capacity or who have “difficulty 
trusting”), more immediate exchanges may be needed; but as Kazdin and Bootzin noted in 
their seminal review, instruction is typically sufficient. Hartzler and Garrett’s data are 
consistent with this observation, but again, studies that expose clients to different delay 
options and then ask them to select one (as opposed to asking a hypothetical question) are 
needed to better understand real-world applicability.
Hartzler and Garrett’s discussion reminds us that there is a complicated interplay between 
reinforcer parameters (e.g., schedule, delay, type, magnitude) and the behavior being 
reinforced that has not been fully explored (cf. Beeby & White, 2013; Kyonka, 2008). Basic 
research generally upholds the concatenated generalized matching law (Davison & 
McCarthy, 1988) which assumes the effects of schedule, delay and other reinforcer 
parameters are additive and independent with no complicated interaction effects (Kyonka, 
2008). However, some experts in the field of behavioral economics argue that reinforcer 
parameters do, in fact, interact and combine to affect behavior (e.g., Beeby & White, 2013). 
Clearly, more discussion and inquiry into this potential interplay between reinforcement 
parameters and behavior is warranted in the human and non-human animal research fields.1
Finally, Hartzler and Garrett’s findings suggest that, at least for the parameters of 
reinforcement schedule and delay (of token exchange), client preferences do not conflict 
1M. Ennis Soreth, personal communication, November 18, 2015.
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with the science underlying well-established guidelines for effective contingency 
management. However, the study raises the following question: If future studies find some 
client preferences that are in conflict with guidelines for the effective use of CM, should we 
accommodate them? Perhaps some parameters of CM should not be negotiable, because 
modifying them would render the treatment ineffective. In other areas of medicine, we might 
allow patients a choice between different treatments or even no treatment. However, patients 
are not invited to choose options that are costly and ineffective. Drawing from these 
illustrations, a more important question might be: What types of client preferences can be 
accommodated without compromising the cost-effectiveness of CM?
This brings us to López-Núñez and her colleagues’ study in this issue of AJDAA which 
addresses the cost-effectiveness of a particular CM intervention by examining the costs and 
smoking cessation outcomes of a cognitive-behavioral treatment (CBT) alone relative to the 
same CBT treatment with CM added (CMT+CM). Their original efficacy study (Secades-
Villa et al., 2014) found abstinence rates at 6 months were nearly twice as high for 
individuals randomly assigned to the CBT+CM condition (51.2%) compared to individuals 
assigned to the CBT-only condition (28.6%; p=.045). CBT+CM also produced longer 
durations of continuous abstinence (11.95 weeks vs. 6.89 weeks; p=.058) at follow-up, and 
statistically significant end-of-treatment group differences in the number of cotinine-free 
specimens (3.79 vs. 2.29; p=.003). In their present analysis, López-Núñez al. report that the 
cost of adding CM to increase the longest duration of continuous abstinence by 1 week was 
€53.92 (US$ 58.39) and that the cost to increase the number of participants maintaining 
abstinence at 6 months by 1 participant was €68.22 (US$ 73.88).
One of the challenges of cost-effectiveness studies is that they can appear complicated, 
technical, and difficult for policy-makers and other outsiders to interpret. For example, 
López-Núñez et al. report that it costs nearly €54 (US$ 59) for one more week of smoking 
abstinence, but do not specify if this is the amount per participant (presumably it is as other 
values are stated per participant; see Table 3). We wonder whether these results would be 
compelling to most policy-makers. How many added weeks of abstinence would be needed 
to be clinically meaningful; that is, to improve a client’s quality of life or reduce health 
complications due to smoking? It may be more helpful for decision-makers to know that as 
the cost of CM increases the net benefits of CM increase disproportionately. While this 
information is possibly more compelling, policy-makers may still be left wondering who 
realizes these benefits and exactly how are they expressed. Despite these communication 
challenges, the message is clear that CM substantially increases smoking abstinence and that 
investing small additional amounts of money can result in greater benefits. Perhaps the 
simplest and most compelling to policy-makers is the comparison López-Núñez et al. draw 
between these results with those of previous studies, where the incremental cost per quitter 
of adding CM to CBT was US$ 281.00 compared to other pharmacological and computer-
based interventions ranging in cost from £222 (US$ 345.66) to US$ 3,781.
The findings of López-Núñez et al. and similar types of analyses have significant policy 
implications for treatment administrators as well as state and federal policy makers. As the 
authors note, these cost-effectiveness analyses can be used as a decision-making tool to 
determine how best to allocate limited financial resources to evidence-based interventions 
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aimed at improving health functioning and to estimate how much clinical “return” can be 
expected based on the money invested. A question that may emerge from these analyses is 
whether stigma interferes with payers’ (e.g., managed care) willingness to fund similar 
programs for other substances of abuse (e.g., opioids, cocaine). Within this realm, it may be 
worthwhile for future researchers to survey payers’ beliefs related to what these 
organizations are willing to invest in CM to obtain these expected returns.
Considering López-Núñez et al,’s impressive findings in terms of both affordability and 
effectiveness utilizing a CBT+CM approach for smoking cessation, one question that 
emerges (and needs to be assessed in future studies) is whether findings of this cost-
evaluation will hold across different settings, diverse populations, different substances of 
abuse, and/or different schedules of reinforcement. Demonstrating that these findings 
support the use of CM, while continuing to demonstrate the same “return,” will be critical in 
further convincing payers to invest in adding CM to existing treatment programs. 
Consideration should also be given to expected treatment duration, in that it is likely that this 
may vary by substance use severity and possibly by substance of abuse.
López-Núñez et al.’s secondary analysis is consistent with previous research demonstrating 
that CM is efficacious in increasing smoking abstinence and adds to a growing body of 
literature demonstrating cost-effectiveness of CM interventions. Hartzler and Garrett’s work 
encourages us to consider client preferences when formulating and implementing CM 
procedures, which may facilitate greater client investment in treatment and positively impact 
motivation for change. In considering both studies, although modifying CM to match client 
preferences may result in highly individualized interventions and further complicate our 
ability to determine CM’s cost-effectiveness per participant, it is our hope that future 
research on CM procedures will yield results that will allow treatment providers to adopt a 
more client-centered approach while maintaining its cost-effectiveness and will encourage 
payers to allocate funding for CM.
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